"Chart & Float ( "Top 40" ) chart

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone PoemStone #54802
318
"Chart & Float ( "Top 40" ) chart picks

2014789399_stockshares.jpg

A word to the wise:
"Stock picking is work".
"The stock market
is all about work."

"Just you and it "

1256418079_theride.jpg

We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving always makes a list.

Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.


The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.

Barchart daily regardless of float:
Top 1% inc 100% x 100% strong buys.


Big Time Triple 000 Board
A friend at iHub.
Trader53: "At certain times
it is worth it to take a "Trip".
Triple 000 iBox.



bit.ly/2rHWOLk

And Now Today's Top [ 47 ] Hits:

Called From $0.0003 To $25.00
...................................................

$NUZE breakout .80 to $1.19
OTC
Website ultra low float 22.19 M
too new under 6 months for Barchart opinion
filings and news


..................................................

$SWMM breakout candle $0.0095
OTC
Website ultra low float 9.6 M
100% x 100% strong buy
filings and news



..................................................

$CETY breakout $0.095
OTC
Website float 137.94 M
33% x 60% buy
filings and news 3/20/18
Another Biomass Plant In North America
Selects CETY's Waste Heat Generator
Video: https://www.youtube.com/watch?v=SdPYD9pTGy4


CETY-HOME.png
...................................................

$LIQT new volume gap $0.42
AMEX
Website low float 32.3 M
33% x 60% buy
filings and news



...................................................

$AMMX Pr upturn $0.0084
OTC thin
Website float 207,498,438
50% x 100% strong buy
filings and news
3/22/18 Receives $4.25 Million Order


amerimex_logo.jpg
...................................................

$HOLL upturn $0.74
OTC
Website { O/S 16,131,477 }
hold x 100% buy
filings and news


..................................................

$NDLS YTD $5.25 to $7.91
Nasdaq GS
Website ultra low float 24.95 M
100% x 100% strong buy
filings and news



..................................................

$CLNE new volume upturn $1.50
Nasdaq GM
Website float 133.46 M
67% sell x 60% buy
filings and news



...................................................

$CASI Pr candle $3.19 to $3.91
Nasdaq CM
Website ultra low float 29.9 M
60% x 75% buy
filings and news 3/20/18
$50M private raise ahead of China debut



..................................................

$PFIE staging $2.66
Nasdaq CM
Website ultra low float
11,383,000 M
80% x 100% strong buy
filings and news



....................................................

$AKER at breakout $0.80
Nasdaq CM
Website ultra low float 19.46 M
33% x 100% buy
filings and news



..................................................

$F staging $11.00
NYSE
Website float 3.89 B
67% sell x 40% buy
Ford Investors page



...................................................

$FCSC at resistance $0.70
Nasdaq CM
Website Ultra low float 14.12 M
67% sell x 40% buy
filings and news


fibrocell-logo.png
...................................................

$DIRV breakout $0.048 to $0.011
OTC
Website ultra low float 16.88 M
67% sell x 60% buy
filings and news


logo_wo_tag-horizontal-300x90.jpg
..................................................

$GTIM breakout $2.75 to $3.20
Nasdaq CM
Website ultra low float 11.55 M
33% x 100% strong buy
filings and news


Goodtimes_Logo_Web-420x315.png
..................................................

$ARQL breakout $1.95 to $2.25
Nasdaq GM
Website low float 79.53 M
100% x 100% strong buy
filings and news
FDA's BTD tag for J&J's erdafitinib
stokes buying in competitor ArQule

ArQule-Inc..jpg
.................................................

$BRFH gap recovery Pr $0.50
OTC an ol' fav
Website low float 49 M
hold x 60% buy
filings and news 2/08/18 National Account
Rollout to over 1000 Foodservice Locations



...................................................

$AMTX breakout $1/19 to $2.46
Nasdaq GM
Website ultra low float 14.06 M
100% x 100% strong buy
filings and news 3/16/18
Completes Construction of Advanced Biodiesel
Pre-Treatment Unit Required for BP Supply Agreement

fulllogo.png

...................................................

$WTER time to call it $0.90
OTC
triple bottom / increasing revenues
Website ultra low float 14,679,095
25% x 67% strong sell
filings and news



..................................................

$ACGX staging $0.0025
OTC
Website float 1.69 B
80% x 100% strong buy
filings and news


logo.png
...................................................

$ETBI rising on 10 day $0.0042
OTC
Website float 130 M
60% x 100% strong buy
filings and news


logo.jpg
...................................................

$RNVA new volume candle $0.0067
OTC
Website ultra low float 5.6 M
20% x 67$ sell
filings and news


header_logo.png
..................................................

$PRPH breakout $2.42
Nasdaq GM
Website ultra low float 12.4 M
100% x 100% strong buy
filings and news


CherrySlim100.png
....................................................

$HAON Pr $0.0003
OTC bot .0002
Website float 6.73 B
hold x 33% buy
filings and news 2/28/18
Q-10 #4 revenues


mV2ZXbTA_400x400.jpg
...................................................

$LIGA approaching breakout
OTC $0.0075
Website float 2.04 B
75% x 100% strong buy
filings and news

NO_LIGA.png
...................................................

$LVVV staging on 10 day $0.02
OTC
Website float 477,383,726
20% x 67% buy
filings and news



..................................................

$GCEI at resistance $0.008
OTC
Website ultra low float 20.36 M
20% x 67% buy
filings and news


gceipink.png
...................................................

$KMPH staging & a Pr $6.00
Nasdaq GM
Website ultra low float 11.61 M
60% x 75% buy
filings and news 2/23/18
FDA approves KemPharm's Apadaz


kem-logo.png
....................................................

$PSPW at resistance $0.15
OTC
Website float 241.68 M
100% x 100% strong buy
filings and news


logo.png
...................................................

$IVST staging on 10 day $ 0.09
OTC
Website ultra low float 11,796,710
33% x 100% buy
filings and news



...................................................

$BIEL Triple 0 staging $0.0009
OTC
Website O/S shares 18,076,403,191 B
hold x 67% buy
filings and news


BioElectronics-Logo-with-tagline-1-e1462835964289.png
..................................................

$AMRS at resistance $5.25
Nasdaq GM
Website ultra low float 27.3 M
67% x 80% buy
filings and news

logo.png
...................................................

$RXMD breakout $0.038 to $0.05
OTC
Website float 313,793,000 M
100% x 100% strong buy
filings and news


logo.png
...................................................

$REPR at resistance Pr $1.10
OTC
Website ultra low float 21,159,887
100% x 100% buy
filings and news 2/13/18
Double-Digit Percentage Growth in Net Sales


RMS_Medical_Products_logo_small.png
...................................................

$SNWV breakout $0.20
OTC
Website float 117,831,526
50% x 100% buy
filings and news - 2/13/18
Enters VA, Indian Health Services,
and Military Base Market; Revenues
Expected to Occur Immediately


logo.png
...................................................

$FUSZ staging on 10 day $0.33
OTC
Website low float 39.7 M
100% x 100% strong buy
filings and news


nFusz-Black-SMALL.png
...................................................

$APPS at breakout $2.11
Nasdaq CM
Website low float 64.9 M
100% x 100% buy
filings and news


logo.png
...................................................

$EVK breakout $2.70
Nasdaq GM
Website-China ultra low float 4.2 M
80% x 100% strong buy
filings and news



...................................................

$EVSI at breakout $0.18
OTC
Website low float 92.8 M
33% x 80% buy
filings and news2/8/18
Record Monthly Revenues


logo.jpg
..................................................

$ADTM exclusive to MJ financing $0.0008
OTC
(N/A)Website float 172.43 M
20% x 67% buy
filings and news 1/12/19 Restructures
Into Pure Play Cannabis Company


New logo and website coming.

...................................................

$SHMN .0007 to .0022 $0.0007
OTC
website float 535.2 M
100% x 100% strong buy
filings and news


SOHM.jpg
...................................................

$STEV on 10 day $0.0054
OTC
Website float 192 M
20% x 67% buy
filings and news



...................................................

$RQHTF climber .55 to 1.40
OTCQB
Website low float 81.1M
80% x 100% strong buy
filings and news



..................................................

$ONCI off the bottom
OTC $0.0018
Website float 346M
67% sell x 20% buy
filings and news



..................................................

$USRM bot back in at resistance $0.047
OTC
Website float 327M
80% x 100% strong buy
Filings and news

ussc-logo-web1.jpg
..................................................

$IO big steps $3.65 to $25.00
NYSE website ultra low float 8.8M
100% x 100% strongbuy
filings and news


.....................................................

$ZYXI 5-bagger $0.68 & $4.71
OTC
Website ultra low float 19.35M
A 5-bagger at $3.40 1/11/18
20% x 100% buy
filings and news


zynex-medical-logo.png
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading